Article Versions Notes

Huang J-C, Pan B, Wang H-X, Chen Q, He Q, Lyu S-C. Prognostic Value of Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Carcinoma Followed by Pancreatectomy with Portal Vein Resection and Reconstruction with Venous Allograft. Journal of Clinical Medicine. 2022; 11(24):7380. https://doi.org/10.3390/jcm11247380

Huang, Jin-Can, Bing Pan, Han-Xuan Wang, Qing Chen, Qiang He, and Shao-Cheng Lyu. 2022. "Prognostic Value of Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Carcinoma Followed by Pancreatectomy with Portal Vein Resection and Reconstruction with Venous Allograft" Journal of Clinical Medicine 11, no. 24: 7380. https://doi.org/10.3390/jcm11247380

Huang, J.-C., Pan, B., Wang, H.-X., Chen, Q., He, Q., & Lyu, S.-C. (2022). Prognostic Value of Neoadjuvant Chemotherapy in Patients with Borderline Resectable Pancreatic Carcinoma Followed by Pancreatectomy with Portal Vein Resection and Reconstruction with Venous Allograft. Journal of Clinical Medicine, 11(24), 7380. https://doi.org/10.3390/jcm11247380